Microbot Medical (MBOT) Registration filing summary

Management team and governance

• CEO, President, and Chairman is Harel Gadot, with additional executive officers including Rachel Vaknin (CFO) and directors such as David J. Wilson, Prattipati Laxminarain, Scott Burell, Martin Madden, Aileen Stockburger, and Tal Wenderow.

• Directors and officers are covered by indemnification agreements and a directors' and officers' insurance policy.

• Employment and compensation agreements are in place for key executives, with several amendments and addenda filed.

Risk factors and disclosures

• Indemnification for directors and officers is provided to the fullest extent permitted by Delaware law, with limitations for breaches of loyalty, bad faith, or unlawful acts.

• The company maintains insurance and indemnification agreements to attract and retain qualified leadership.

• SEC may consider certain indemnification provisions unenforceable as contrary to public policy.

Offering details and pricing

• Registration statement filed for the sale of common stock, with offerings to be made from time to time after the effective date.

• Estimated total expenses for the offering are $35,000, including SEC fees, legal, accounting, and miscellaneous costs.

• Securities offered include common stock and various series of preferred investment options and warrants, with exercise prices ranging from $1.50 to $4.64 per share in recent private placements.